TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

53.07 -1.80 (-3.28%)

Streaming Delayed Price Updated: 12:07 PM EDT, Jul 29, 2026 Add to My Watchlist

Price and Volume

Volume	557,454
Open	54.87
Bid (Size)	53.05 (300)
Ask (Size)	53.10 (100)
Prev. Close	54.87
Today's Range	53.01 - 54.98
52wk Range	25.28 - 59.30
Shares Outstanding	154,420,772
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

TG Therapeutics (NASDAQ:TGTX) Meets Minervini's Trend Template with Accelerating Growth ↗

Today 8:30 EDT

Via Chartmill

2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗

July 08, 2026

Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.

Via The Motley Fool

Performance

YTD	+81.2%	+81.2%
1 Month	-4.8%	-4.8%
3 Month	+53.5%	+53.5%
6 Month	+72.3%	+72.3%
1 Year	+47.5%	+47.5%

More News

TG THERAPEUTICS INC (NASDAQ:TGTX): High-Growth Momentum Meets Minervini Trend Template Technical Strength ↗

July 02, 2026

Via Chartmill

The Quest to Repair What Multiple Sclerosis Takes Away

June 24, 2026

Via Investor Brand Network

TG THERAPEUTICS INC (NASDAQ:TGTX) Screens as Affordable Growth Play with Strong Revenue Surge and Discounted Valuation ↗

May 09, 2026

Via Chartmill

TG Therapeutics (NASDAQ:TGTX) Q1 2026 Earnings Beat Revenue Guidance but Miss EPS Estimates ↗

May 06, 2026

Via Chartmill

TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside ↗

April 20, 2026

Via Chartmill

TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum ↗

April 04, 2026

Via Chartmill

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

June 24, 2026

Via Investor Brand Network

The Quest to Repair What Multiple Sclerosis Takes Away

June 24, 2026

From BioMedWire

Via GlobeNewswire

TG Therapeutics Inc (NASDAQ:TGTX) Presents a Compelling Momentum Case with Strong Growth and Technical Setup ↗

March 14, 2026

Via Chartmill

TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook ↗

February 26, 2026

Via Chartmill

TG Therapeutics Stock Pops As Briumvi Boom Reignites Bull Case: Goldman Sachs Sees Room For 32% Rally ↗

January 15, 2026

Via Stocktwits

TG Therapeutics Stock Surges After Drug Trial Update ↗

June 03, 2026

Via Benzinga

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗

May 30, 2026

Via The Motley Fool

Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position ↗

May 10, 2026

Via The Motley Fool

Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗

May 10, 2026

Via The Motley Fool

TG Therapeutics (TGTX) Q1 2026 Earnings Transcript ↗

May 06, 2026

Via The Motley Fool

TGTX Q1 2025 Earnings Call Transcript ↗

May 06, 2026

Via The Motley Fool

What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗

March 16, 2026

Via The Motley Fool

This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop ↗

March 16, 2026

Via The Motley Fool

TG Therapeutics (TGTX) Q4 2025 Earnings Transcript ↗

February 26, 2026

Via The Motley Fool

Soleus Adds a Significant Number of Celcuity Shares ↗

February 13, 2026

Via The Motley Fool

TG Therapeutics Lights Up Super Bowl With Christina Applegate MS Campaign — Retail Sees 'Huge Win' ↗

February 09, 2026

Via Stocktwits

Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares ↗

February 02, 2026

Via The Motley Fool

Frequently Asked Questions

Is TG Therapeutics, Inc. - Common Stock publicly traded?

Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does TG Therapeutics, Inc. - Common Stock trade on?

TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?

The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market

What is the current price of TG Therapeutics, Inc. - Common Stock?

The current price of TG Therapeutics, Inc. - Common Stock is 53.07

When was TG Therapeutics, Inc. - Common Stock last traded?

The last trade of TG Therapeutics, Inc. - Common Stock was at 07/29/26 12:07 PM ET

What is the market capitalization of TG Therapeutics, Inc. - Common Stock?

The market capitalization of TG Therapeutics, Inc. - Common Stock is 8.20B

How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?

TG Therapeutics, Inc. - Common Stock has 8B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.